NAPWA

While it has long been acknowledged that successful antiretroviralA medication or other substance which is active against retroviruses such as HIV. treatment and an undetectable viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. lowers the risk of passing on HIV, we have little research to support the fact. read more »

PRO 2000, the microbicide gel, has failed to protect women against HIV infection in the largest microbicide study to date. read more »

The Conference on Retroviruses and Opportunistic Infections (CROI) has just happened in San Francisco. This meeting is held annually and focuses on the very latest in basic science and clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. research. Jo Watson was there and gives us an overview. read more »

A treatment regimen consisting of one nonnucleoside (1NNRTI) and two nucleosides (2NRTIs) has become the internationally accepted first-line therapy of choice. But effective as the combination is, it doesn’t work for everyone. And those it fails need a reliable back-up. read more »

The Seroconversion Study collects both quantitative and qualitative data from mainly homosexual men who have recently been diagnosed with HIV. Men are referred to the online questionaire through clinics and HIV organisations providing services to men who are newly diagnosed. Men completing the online questionaire volunteer for the more extended depth interview. read more »

Those of us with HIV are more likely to have conditions such as osteopenia (low bone mineral density) and osteoporosis (weakened bones) than our negative contemporaries. read more »

An international trial that has just started enrollingThe act of signing up participants into a study. Generally this process involves evaluating a participant with respect to the eligibility criteria of the study and going through the informed consentThe process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. process. in Australia aims to determine whether it is better to start treatment earlier, when T-cell counts are above 500, or when they drop to 350 as per the current recommendations. read more »

The Bill and Melinda Gates Foundation has granted AUD $12.4 million to the University of NSW to study whether lower doses of some commonly used antiretroviralA medication or other substance which is active against retroviruses such as HIV. drugs are as effective as currently prescribed doses. read more »

At the opening plenary of the 20th Australasian Society of HIV Medicine (ASHMAustralasian Society for HIV Medicine. The peak Australasian organisation representing the medical and health sector in HIV/AIDS and related areas. ) Conference in Perth on July 17-20, the Presidents of ASHM, AFAOAustralian Federation of AIDS Organisations. AFAO is the peak non-government organisation representing Australia's community-based response to HIV/AIDS. AFAO's work includes education, policy, advocacy and international projects. and NAPWA all condemned recent trends by governments around the world to criminalise the transmission of HIV. read more »

The National Health and Medical Research Council (NHMRC) is currently undertaking a review of the National Statement on Ethical Conduct in Research Involving Humans (1999). NAPWA has made submission to the review. read more »